Medtronic's most recent trend suggests a bullish bias. One trading opportunity on Medtronic is a Bull Put Spread using a strike $64.50 short put and a strike $59.50 long put offers a potential 8.23% return on risk over the next 12 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $64.50 by expiration. The full premium credit of $0.38 would be kept by the premium seller. The risk of $4.62 would be incurred if the stock dropped below the $59.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Medtronic is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Medtronic is bullish.
The RSI indicator is at 66.09 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Medtronic
Inversion crackdown all talk, no action?
Mon, 08 Sep 2014 21:50:00 GMT
Treasury's Lew urges action on “inversion” tax deals
Mon, 08 Sep 2014 20:41:59 GMT
Reuters – Treasury Secretary Jack Lew called on Monday for prompt action to stem the surge of U.S. While proposals stacked up in Congress, Lew said the Treasury Department was evaluating “what we can do to make these deals less economically appealing, and we plan to make a decision in the very near future.” Senator Chuck Schumer, the No. 3 Senate Democrat, was circulating a draft bill to attack “earnings stripping” often associated with inversions. It was said to be applicable retroactively to deals as far back as 1994.
Pursuing tax inversion solutions
Mon, 08 Sep 2014 19:35:00 GMT
CNBC – Discussing inversion solutions and who has the greater authority to address tax inversions, Congress or the Obama administration, with Rep. Chris Van Hollen, (D-Md.).
Medtronic Up on CE Mark Win for CoreValve Evolut R System
Mon, 08 Sep 2014 14:40:02 GMT
Faber Report: Jack Lew speaks out
Mon, 08 Sep 2014 13:42:00 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook